Using blood brain barrier disruption by methamphetamine for drug delivery

Journal of Neuro-Oncology

Volumn 85, Issue 1, 2007, Pages 109-110

  Kast, R E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; METHAMPHETAMINE; METHOTREXATE;

ATTENTION DEFICIT DISORDER; BLOOD BRAIN BARRIER; BRAIN CANCER; BRAIN CAPILLARY; CAPILLARY PERMEABILITY; CENTRAL NERVOUS SYSTEM TUMOR; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG PENETRATION; HUMAN; LETTER; LONG TERM CARE; NONHUMAN; RISK BENEFIT ANALYSIS; SHORT COURSE THERAPY;

ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG DELIVERY SYSTEMS; HUMANS; METHAMPHETAMINE;

EID: 34548794934     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9389-0     Document Type: Letter

References (6)

1. Kunwar S, Prados MD, Chang SM, Berger MS, Lang FF, Piepmeier JM, Sampson JH, Ram Z, Gutin PH, Gibbons RD, Aldape KD, Croteau DJ, Sherman JW, Puri RK, Cintredekin Besudotox Intraparenchymal Study Group (2007) Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25(7):837-844
2. Doolittle ND, Peereboom DM, Christoforidis GA, Hall WA, Palmieri D, BrockPR, Campbell KC, Dickey DT, Muldoon LL, O'Neill BP, Peterson DR, Pollock B, Soussain C, Smith Q, Tyson RM, Neuwelt EA (2007) Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: Report of the Eleventh Annual Blood-Brain Barrier Consortium meeting. J Neurooncol 81(1):81-91
3. Sharma HS, Ali SF (2006) Alterations in blood-brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci 1074:198-224
4. Bowyer JF, Ali S (2006) High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 60(7):521-532
5. Quinton MS, Yamamoto BK (2006) Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 8(2):E337-E347
6. Lee YW, Hennig B, Yao J, Toborek M (2001) Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res 66(4):583-591